[1]周腾飞,朱良付,李天晓.影响急性缺血性脑卒中血管内治疗预后的相关因素分析[J].介入放射学杂志,2017,(02):99-104.
　ZHOU Tengfei,ZHU Liangfu,LI Tianxiao.Analysis of factors influencing the prognosis of patients with acute ischemic stroke receiving endovascular treatment[J].journal interventional radiology,2017,(02):99-104.
点击复制

影响急性缺血性脑卒中血管内治疗预后的相关因素分析()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年02期
页码:
99-104
栏目:
专论
出版日期:
2017-02-25

文章信息/Info

Title:
Analysis of factors influencing the prognosis of patients with acute ischemic stroke receiving endovascular treatment
作者:
周腾飞;  朱良付;  李天晓
Author(s):
ZHOU Tengfei;  ZHU Liangfu;  LI Tianxiao
Department of Interventional Therapy， Zhengzhou University People’s Hospital， Henan Provincial People’s Hospital， Zhengzhou， Henan Province 450003， China
关键词:
【关键词】 急性缺血性脑卒中;  血管内治疗;  预后因素
文献标志码:
A
摘要:
【摘要】 随着多项大型临床试验研究结果发布，血管内治疗（或联合静脉溶栓）被推荐为颅内大血管闭塞所致急性缺血性脑卒中患者首选治疗措施。然而，血管内再通治疗预后受到一系列因素影响。该文就影响血管内治疗预后的可能因素作一综述。

参考文献/References:

［1］ Mulder MJ， van Oostenbrugge RJ， Dippel DW， et al. Letter by Mulder et al， Regarding article，“2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment： A guideline for healthcare professionals from the American Heart Association/American Stroke Association”［J］. Stroke， 2015， 46： e235.
［2］ 高 峰， 徐安定． 急性缺血性卒中血管内治疗中国指南2015［J］． 中国卒中杂志， 2015， 10： 590?-606．
［3］ Jauch EC， Saver JL， Adams HP， et al. Guidelines for the early management of patients with acute ischemic stroke： a guideline for healthcare professionals from the American Heart Association/American Stroke Association［J］. Stroke， 2013， 44： 870?-947.
［4］ Clark WM， Wissman S， Albers GW， et al. Recombinant tissue?-type plasminogen activator （Alteplase） for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study： a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke［J］. JAMA， 1999， 282： 2019?-2026.
［5］ Hacke W， Kaste M， Bluhmki E， et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke［J］. J Vasc Surg， 2008， 48： 1634?-1635.
［6］ Xu AD， Wang YJ， Wang DZ， et al. Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel［J］. CNS Neurosci Ther， 2013， 19： 543?-548.
［7］ Broderick JP， Palesch YY， Demchuk AM， et al. Endovascular therapy after intravenous t?-PA versus t?-PA alone for stroke［J］. N Engl J Med， 2013， 368： 893?-903.
［8］ Ciccone A， Valvassori L， Investigators SE. Endovascular treatment for acute ischemic stroke［J］. N Engl J Med， 2013， 368： 2433?-2444.
［9］ Kidwell CS， Jahan R， Gornbein J， et al. A trial of imaging selection and endovascular treatment for ischemic stroke［J］. N Engl J Med， 2013， 368： 914?-923.
［10］ Berkhemer OA， Fransen PS， Beumer D， et al. A randomized trial of intraarterial treatment for acute ischemic stroke［J］. N Engl J Med， 2015， 372： 11?-20.
［11］ Campbell BC， Mitchell PJ， Kleinig TJ， et al. Endovascular therapy for ischemic stroke with perfusion?-imaging selection［J］. N Engl J Med， 2015， 372： 1009?-1018.
［12］ Goyal M， Demchuk AM， Menon BK， et al. Randomized assessment of rapid endovascular treatment of ischemic stroke［J］. N Engl J Med， 2015， 372： 1019?-1030.
［13］ Jovin TG， Chamorro A， Cobo E， et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke［J］. N Engl J Med， 2015， 372： 2296?-2306.
［14］ Saver JL， Goyal M， Bonafe A， et al. Stent?-retriever thrombectomy after intravenous t?-PA vs. t?-PA alone in stroke［J］. N Engl J Med， 2015， 372： 2285?-2295.
［15］ Levy EI， Siddiqui AH， Crumlish A， et al. First Food and Drug Administration?-approved prospective trial of primary intracranial stenting for acute stroke： SARIS （stent?-assisted recanalization in acute ischemic stroke）［J］. Stroke， 2009， 40： 3552?-3556.
［16］ Barber PA， Demchuk AM， Zhang J， et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score［J］. Lancet， 2000， 355： 1670?-1674.
［17］ Demchuk AM， Hill MD， Barber PA， et al. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study［J］. Stroke， 2005， 36： 2110?-2115.
［18］ Yoo AJ， Zaidat OO， Chaudhry ZA， et al. Impact of pretreatment noncontrast CT Alberta Stroke Program Early CT Score on clinical outcome after intra?-arterial stroke therapy［J］. Stroke， 2014， 45： 746?-751.
［19］ Hacke W， Kaste M， Fieschi C， et al. Randomised double?-blind placebo?-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke（ECASSⅡ）. Second European?-Australasian Acute Stroke Study Investigators［J］. Lancet， 1998， 352： 1245?-1251.
［20］ Thijs VN， Lansberg MG， Beaulieu C， et al. Is early ischemic lesion volume on diffusion?-weighted imaging an independent predictor of stroke outcome? A multivariable analysis［J］. Stroke， 2000， 31： 2597?-2602.
［21］ Zaidi SF， Aghaebrahim A， Urra X， et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy［J］. Stroke， 2012， 43： 3238?-3244.
［22］ Lansberg MG， Straka M， Kemp S， et al. MRI profile and response to endovascular reperfusion after stroke （DEFUSE 2）： a prospective cohort study［J］. Lancet Neurol， 11： 860?-867.
［23］ Smith WS， Lev MH， English JD， et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA［J］. Stroke， 2009， 40： 3834?-3840.
［24］ Zheng F， Xie WX. Imaging?-Based patient selection and endovas?蛳cular therapy of ischemic stroke： a stratified Meta?蛳Analysis［J］. Medicine （Baltimore）， 2015， 94： e1539.
［25］ Cooray C， Fekete K， Mikulik R， et al. Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis［J］. Int J Stroke， 2015， 10： 822?-829.
［26］ Bang OY， Saver JL， Kim SJ， et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke［J］. Stroke， 2011， 42： 693?-699.
［27］ Liebeskind DS， Jahan R， Nogueira RG， et al. Impact of collaterals on successful revascularization in Solitaire FR with the intention for thrombectomy［J］. Stroke， 2014， 45： 2036?-2040.
［28］ Lees KR， Bluhmki E， Von Kummer R， et al. Time to treatment with intravenous alteplase and outcome in stroke： an updated pooled analysis of ECASS， Atlantis， NINDS， and EPITHET trials［J］. Lancet， 2010， 375： 1695?-1703.
［29］ Hassan AE， Chaudhry SA， Miley JT， et al. Microcatheter to recanalization（procedure time） predicts outcomes in endovascular treatment in patients with acute ischemic stroke： when do we stop?［J］. AJNR Am J Neuroradiol， 2013， 34： 354?-359.
［30］ Mosimann PJ， Sirimarco G， Meseguer E， et al. Is intracerebral hemorrhage a time?-dependent phenomenon after successful com?-bined intravenous and intra?-arterial therapy?［J］. Stroke， 2013， 44： 806?-808.
［31］ Mazighi M， Chaudhry SA， Ribo M， et al. Impact of onset?-to?-reperfusion time on stroke mortality： a collaborative pooled analysis［J］. Circulation， 2013， 127： 1980?-1985.
［32］ Abou?-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients［J］. Stroke， 2010， 41： 1996?-2000.
［33］ Alshekhlee A， Pandya DJ， English J， et al. Merci mechanical thrombectomy retriever for acute ischemic stroke therapy：literature review［J］. Neurology， 2012， 79（13 Suppl 1）： S126?-S134.
［34］ Todo A， Minaeian A， Sahni R， et al. Incidence and outcome of procedural distal emboli using the Penumbra thrombectomy for acute stroke［J］. J Neurointerv Surg， 2013， 5： 135?-138.
［35］ 王洪生， 刘 圣， 赵林波， 等． Solitaire AB型支架取栓治疗急性大脑中动脉栓塞疗效分析［J］． 介入放射学杂志， 2015， 24： 658?-661．
［36］ Saver JL， Jahan R， Levy EI， et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke （SWIFT）： a randomised， parallel?-group， non?-inferiority trial［J］. Lancet， 2012， 380： 1241?-1249.
［37］ Nogueira RG， Lutsep HL， Gupta R， et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke （TREVO 2）： a randomised trial［J］. Lancet， 2012， 380： 1231?-1240.
［38］ Almekhlafi MA， Menon BK， Freiheit EA， et al. A meta?-analysis of observational intra?-arterial stroke therapy studies using the Merci device， Penumbra system， and retrievable stents［J］. AJNR Am J Neuroradiol， 2013， 34： 140?-145.
［39］ Grech R， Pullicino R， Thornton J， et al. An efficacy and safety comparison between different stentriever designs in acute ischaemic stroke： a systematic review and meta?-analysis［J］. Clin Radiol， 2016， 71： 48?-57.
［40］ Bhatnagar P， Sinha D， Parker RA， et al. Intravenous thrombolysis in acute ischaemic stroke： a systematic review and meta?-analysis to aid decision making in patients over 80 years of age［J］. J Neurol Neurosurg Psychiatry， 2011， 82： 712?-717.
［41］ Duffis EJ， He W， Prestigiacomo CJ， et al. Endovascular treatment for acute ischemic stroke in octogenarians compared with younger patients： a meta?-analysis［J］. Int J Stroke， 2014，9： 308?-312.
［42］ Zacharatos H， Hassan AE， Vazquez G， et al. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older［J］. Am J Emerg Med， 2012， 30： 158?-164.
［43］ Sandercock P， Wardlaw JM， Lindley RI， et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke （the third international stroke trial［IST?-3］）： a randomised controlled trial［J］. Lancet， 2012， 379： 2352?-2363.
［44］ Pan YE， Chen QD， Liao XL， et al. Preexisting dual antiplatelet treatment increases the risk of post?-thrombolysis intracranial hemorrhage in Chinese stroke patients［J］. Neurol Res， 2015， 37： 64?-68.
［45］ Pan X， Zhu Y， Zheng D， et al. Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke： a meta?-analysis of cohort studies and randomized controlled trials［J］. Int J Stroke， 2015， 10： 317?-323.
［46］ Kellert L， Hametner C， Rohde S， et al. Endovascular stroke therapy： tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome［J］. Stroke， 2013， 44： 1453?-1455.
［47］ Kim JW， Jeon P， Kim GM， et al. Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke： preliminary experience and short term follow?-up results［J］. Clin Neurol Neurosurg， 2012， 114： 1316?-1319.
［48］ Seo JH， Jeong HW， Kim ST， et al. Adjuvant tirofiban injection through deployed solitaire stent as a rescue technique after failed mechanical thrombectomy in acute stroke［J］. Neurointervention， 2015， 10： 22?-27.
［49］ Almekhlafi MA， Davalos A， Bonafe A， et al. Impact of age and baseline NIHSS scores on clinical outcomes in the mechanical thrombectomy using Solitaire FR in acute ischemic stroke study［J］. AJNR Am J Neuroradiol， 2014， 35： 1337?-1340.
［50］ Abou?-Chebl A， Lin R， Hussain MS， et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke： preliminary results from a retrospective， multicenter study［J］. Stroke， 2010， 41： 1175?-1179.

相似文献/References:

[1]唐军,明德国,刘作勤,等.脑动静脉畸形的血管内栓塞治疗[J].介入放射学杂志,2000,(03):144.
[2]黄求理,宋侃侃,施建国,等.血管内治疗基底动脉瘤并发短暂双目失明1例[J].介入放射学杂志,1997,(04):244.
[3]李明华,陈君彦,顾斌贤,等.颅内动脉瘤可解脱弹簧栓塞治疗——附28例分析[J].介入放射学杂志,1998,(04):194.
[4]魏崇健,何洪林,乔英,等.创伤性假性动脉瘤与动静脉瘘的介入治疗(附25例报告)[J].介入放射学杂志,1999,(03):19.
[5]黄正松,戴钦舜.血管内治疗颅内动脉瘤[J].介入放射学杂志,1994,(02):104.
[6]王 武,李明华,顾斌贤.Ｓｏｌｉｔａｉｒｅ ＡＢ支架血管内治疗支架源性弹簧圈移位的脑动脉瘤一例[J].介入放射学杂志,2010,(10):804.
　WANG Wu,LI Ming-hua,GU Bin-xian..Solitaire AB stent management of coil migration associated with stent-assisted coiling of a cerebral aneurysm: report of one case[J].journal interventional radiology,2010,(02):804.
[7]何永福,王武,李明华,等.颈内动脉眼动脉段血泡样动脉瘤合并右位主动脉弓一例[J].介入放射学杂志,2010,(12):1007.
　HE Yong-fu,WANG Wu,LI Ming-hua,et al.A blister-like aneurysm at the ophthalmic segment of internal carotid artery associated with right-sided aortic arch: report of one case[J].journal interventional radiology,2010,(02):1007.
[8]王兴华,王武,陈新国,等.血管内栓塞治疗脊髓血管畸形[J].介入放射学杂志,2010,(12):933.
　WANG Xing-hua,WANG Wu,CHEN Xin-guo,et al.Endovascular embolization for spinal cord vascular malformation[J].journal interventional radiology,2010,(02):933.
[9]王 武,李明华,顾斌贤.Ｗｉｌｌｉｓ覆膜支架治疗难治性外伤性颈动脉海绵窦瘘[J].介入放射学杂志,2011,(03):177.
　WANG Wu,LI Ming-hua,GU Bin-xian..Endovascular treatment of complex traumatic direct carotid-cavernous fistulas by using Willis covered stent[J].journal interventional radiology,2011,(02):177.
[10]张智博,杨鹏飞,黄清海,等.创伤性颅内假性动脉瘤的血管内治疗[J].介入放射学杂志,2011,(04):329.
　ZHANG Zhi-bo,YANG Peng-fei,HUANG Qing-hai,et al.Endovascular treatment of traumatic intracranial pseudoaneurysm[J].journal interventional radiology,2011,(02):329.
[11]杭 宇,王绍显,贾振宇,等.对比剂连续应用对颅内大血管闭塞患者肾功能影响的前瞻性研究[J].介入放射学杂志,2021,30(11):1091.
　HANG Yu,WANG Shaoxian,JIA Zhenyu,et al.The effect of continuous use of iodinated contrast agent on the renal function in patients with occlusion of intracranial large artery： a prospective study[J].journal interventional radiology,2021,30(02):1091.
[12]孟媛媛,钟孟飞,陈晓辉,等.CTA评分对发病6～24 h急性基底动脉闭塞血管内治疗临床结局的预测价值[J].介入放射学杂志,2021,30(11):1100.
　MENG Yuanyuan,ZHONG Mengfei,CHEN Xiaohui,et al.The value of computed tomography angiography score in predicting the clinical outcome of patients with acute basilar artery occlusion receiving endovascular recanalization within 6-24 hours after onset[J].journal interventional radiology,2021,30(02):1100.
[13]杭 宇,贾振宇,曹月洲,等.急性大血管闭塞性脑卒中静脉溶栓后转诊行血管内治疗预后影响因素分析[J].介入放射学杂志,2022,31(04):383.
　HANG Yu,JIA Zhenyu,CAO Yuezhou,et al.Analysis of factors influencing prognosis in patients with acute ischemic stroke due to large vessel occlusion referred to endovascular treatment after receiving thrombolysis[J].journal interventional radiology,2022,31(02):383.

备注/Memo

备注/Memo:
（收稿日期：２０１6-０4-22）
（本文编辑：边 佶）
更新日期/Last Update: 2017-02-13